| Overview |
| bs-18631R-Cy7 |
| MAGOH/Mago nashi homolog 2 Polyclonal Antibody, Cy7 Conjugated |
| IF(IHC-P), IF(IHC-F), IF(ICC) |
| Mouse, Rat |
| Human, Dog, Cow |
| Specifications |
| Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human MAGOH/Mago nashi homolog 2 |
| 51-148/148 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 55110 |
| Q96A72 |
| Nucleus |
| FLJ10292; MAGO; Mago nashi homolog 2; Mago nashi homolog B; MAGOH; MAGOH2; MAGOHB; MGN2; MGN2_HUMAN; Protein mago nashi homolog 2. |
| MAGOHB (Mago Homolog B, Exon Junction Complex Subunit) is a Protein Coding gene. Diseases associated with?MAGOHB include?Metaphyseal Chondrodysplasia, Schmid Type?and?Chromosome 22Q11.2 Deletion Syndrome, Distal. Among its related pathways are?Cleavage of Growing Transcript in the Termination Region?and?Transport of Mature Transcript to Cytoplasm. An important paralog of this gene is?MAGOH. |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz